The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s
Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics
Over the past six months, Fastly’s shares (currently trading at $6.33) have posted a disappointing 14% loss while the S&P 500 was down 3.4%. This was
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the vertical software industry,
JLL trades at $244.01 per share and has stayed right on track with the overall market, losing 7.8% over the last six months while the S&P 500 is down
What a brutal six months it’s been for The Real Brokerage. The stock has dropped 27.1% and now trades at $4.09, rattling many shareholders. This may have
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including NeoGenomics (NASDAQ:NEO) and
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how consumer
Since April 2020, the S&P 500 has delivered a total return of 121%. But one standout stock has doubled the market - over the past five years, Merit
